Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625406 | SCV000745256 | uncertain significance | Retinitis pigmentosa 30 | 2016-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001212477 | SCV001384060 | uncertain significance | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 342 of the FSCN2 protein (p.Arg342Gln). This variant is present in population databases (rs374441539, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FSCN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 522327). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Clinical Genetics, |
RCV001212477 | SCV001924850 | uncertain significance | not provided | no assertion criteria provided | clinical testing |